Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities and Other Current Liabilities

6 Months Ended

Jan. 31, 2012

Note 9 – Accrued Liabilities and Other Current Liabilities

At January 31, 2012 and July 31, 2011, accrued liabilities consist of:


	January 31, 2012		July 31, 2011

Legal	$	803	$	610
Payroll, benefits, and commissions		4,060		4,286
Professional fees		940		782
Research and development		709		709
Other		2,251		1,801

	$	8,763	$	8,188

Other current liabilities consist of the following as of:


	January 31, 2012		July 31, 2011

Liability for purchase price consideration (see Note 13)	$	—	$	1,150
Deferred revenue		385		396
Other		129		137

	$	514	$	1,683